ARC Innovation at Sheba Medical Center in Israel and the Icahn School of Medicine at Mount Sinai in New York unveiled a three-year collaboration with Nvidia to use large language model technology to accelerate genomic discovery.
The initiative, according to a Nov. 18 news release, aims to decode the vast majority of the human genome that remains poorly understood, with the goal of uncovering new avenues for disease prevention, diagnosis and treatment. The participating organizations said they will make significant investments over the three-year period to support the effort.
Sheba and Mount Sinai will contribute large genomic datasets, AI research capabilities and clinical expertise, while NVIDIA will provide computational infrastructure, software and scientific support.
Together, the partners plan to develop an AI-driven genomic research engine to identify patterns and regulatory mechanisms that link genetic variation to disease risk and therapeutic response.
The initiative will begin by targeting areas where genetic complexity has slowed scientific progress.
The effort will be co-led by ARC’s new AI Center at Sheba and Mount Sinai’s Charles Bronfman Institute for Personalized Medicine and Windreich Department of Artificial Intelligence and Human Health. Joint research teams from all three organizations have already begun building the shared platform that will support global scientific and clinical collaboration.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
